Discover 1,070 paid clinical trials in Ogden, Utah. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,070
Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer
for
Endometrial Clear Cell Adenocarcinoma,
Location: Salt Lake City UT, Houston TX, Maywood IL
Sponsor: University of Utah
Sex: All
Age: 0+
Code: NCT03422198
Phase3, Recruiting
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
for
Myelofibrosis
Location: Salt Lake City UT, Denver CO, Duarte CA, Los Angeles CA,
Sponsor: Sumitomo Pharma America, Inc.
Sex: All
Age: 18+
Code: NCT04176198
Phase1, Phase2, Recruiting
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
for
Metastatic Clear Cell Renal Cell Carcinoma,
Location: Salt Lake City UT, Las Vegas NV, Henderson NV,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT04510597
Phase3, Recruiting
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
for
Relapsed/Refractory Multiple Myeloma
Location: Salt Lake City UT, Duarte CA, Irvine CA, Seattle WA,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT04973605
Phase1, Phase2, Recruiting
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
for
Cutaneous Melanoma, Stage II
Location: Salt Lake City UT, Murray UT, Albuquerque NM,
Sponsor: Melanoma and Skin Cancer Trials Limited
Sex: All
Age: 18+
Code: NCT03860883
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia,
Location: Salt Lake City UT, Boise ID, Meridian ID, Nampa ID,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT05554406
Phase2, Recruiting
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
for
cGVHD
Location: Salt Lake City UT, Aurora CO, Phoenix AZ, Duarte CA,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT05919511
Recruiting
Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia With History of Non-melanoma Skin Cancers
for
Chronic Lymphocytic Leukemia, Non-melanoma Skin Cancer (NMSC)
Location: Salt Lake City UT
Sponsor: University of Utah
Sex: All
Age: 18+
Code: NCT04844528
Phase2, Recruiting
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
for
Acute Myeloid Leukemia
Location: Salt Lake City UT, Boise ID, Meridian ID, Nampa ID,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 59
Code: NCT05554393
Phase2, Recruiting
Post-Autologous Transplant Maintenance With Isatuximab and Lenalidomide in Minimal Residual Disease Positive Multiple Myeloma
for
Multiple Myeloma
Location: Salt Lake City UT, Chicago IL
Sponsor: University of Illinois at Chicago
Sex: All
Age: 18+
Code: NCT05344833
Phase2, Recruiting
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
Location: Salt Lake City UT, Aurora CO, Reno NV, Phoenix AZ,
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Sex: All
Age: 18+
Code: NCT04031677
Phase3, Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
for
Triple Negative Breast Cancer
Location: Salt Lake City UT, Farmington NM, Rapid City SD,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT05633654
Phase3, Recruiting
QTX3034 in Patients With KRAS G12D Mutation
for
Solid Tumors
Location: Salt Lake City UT, Denver CO, Los Angeles CA,
Sponsor: Quanta Therapeutics
Sex: All
Age: 18+
Code: NCT06227377
Phase1, Recruiting
Pneumococcal Pneumonia Vaccine Series (PCV20 and PPSV23) in Patients With Chronic Lymphocytic Leukemia Associated Immunodeficiency, PROTECT CLL Trial
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Salt Lake City UT
Sponsor: University of Utah
Sex: All
Age: 18+
Code: NCT05183854
Phase2, Recruiting
Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma